1. Home
  2. PAVM vs KZIA Comparison

PAVM vs KZIA Comparison

Compare PAVM & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVM
  • KZIA
  • Stock Information
  • Founded
  • PAVM 2014
  • KZIA 1994
  • Country
  • PAVM United States
  • KZIA Australia
  • Employees
  • PAVM N/A
  • KZIA N/A
  • Industry
  • PAVM Medical/Dental Instruments
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAVM Health Care
  • KZIA Health Care
  • Exchange
  • PAVM Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • PAVM 8.0M
  • KZIA 6.0M
  • IPO Year
  • PAVM 2016
  • KZIA 1999
  • Fundamental
  • Price
  • PAVM $0.67
  • KZIA $0.98
  • Analyst Decision
  • PAVM Strong Buy
  • KZIA Strong Buy
  • Analyst Count
  • PAVM 1
  • KZIA 2
  • Target Price
  • PAVM $19.00
  • KZIA $11.50
  • AVG Volume (30 Days)
  • PAVM 146.3K
  • KZIA 5.5M
  • Earning Date
  • PAVM 03-25-2025
  • KZIA 03-26-2025
  • Dividend Yield
  • PAVM N/A
  • KZIA N/A
  • EPS Growth
  • PAVM N/A
  • KZIA N/A
  • EPS
  • PAVM 0.53
  • KZIA N/A
  • Revenue
  • PAVM $4,034,000.00
  • KZIA $1,655,324.00
  • Revenue This Year
  • PAVM $52.90
  • KZIA $806.89
  • Revenue Next Year
  • PAVM $248.84
  • KZIA N/A
  • P/E Ratio
  • PAVM $1.27
  • KZIA N/A
  • Revenue Growth
  • PAVM 166.27
  • KZIA 248000.00
  • 52 Week Low
  • PAVM $0.57
  • KZIA $0.91
  • 52 Week High
  • PAVM $3.50
  • KZIA $15.80
  • Technical
  • Relative Strength Index (RSI)
  • PAVM 50.18
  • KZIA 30.47
  • Support Level
  • PAVM $0.62
  • KZIA $1.31
  • Resistance Level
  • PAVM $0.79
  • KZIA $1.60
  • Average True Range (ATR)
  • PAVM 0.06
  • KZIA 0.27
  • MACD
  • PAVM 0.01
  • KZIA 0.02
  • Stochastic Oscillator
  • PAVM 39.70
  • KZIA 4.11

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Share on Social Networks: